Cited by 44Cholesterol and Lipid MetabolismLipoproteins and Cardiovascular HealthLipid metabolism and disorders

The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index; 24 of the 34 sources its claims cite were checked for support.

The hepatic WASH complex is required for efficient plasma LDL and HDL cholesterol clearance

Open access

Abstract

The evolutionary conserved Wiskott-Aldrich syndrome protein and SCAR homolog (WASH) complex is one of the crucial multiprotein complexes that facilitates endosomal recycling of transmembrane proteins. Defects in WASH components have been associated with inherited developmental and neurological disorders in humans. Here, we show that hepatic ablation of the WASH component Washc1 in chow-fed mice increases plasma concentrations of cholesterol in both LDLs and HDLs, without affecting hepatic cholesterol content, hepatic cholesterol synthesis, biliary cholesterol excretion, or hepatic bile acid metabolism. Elevated plasma LDL cholesterol was related to reduced hepatocytic surface levels of the LDL receptor (LDLR) and the LDLR-related protein LRP1. Hepatic WASH ablation also reduced the surface levels of scavenger receptor class B type I and, concomitantly, selective uptake of HDL cholesterol into the liver. Furthermore, we found that WASHC1 deficiency increases LDLR proteolysis by the inducible degrader of LDLR, but does not affect proprotein convertase subtilisin/kexin type 9–mediated LDLR degradation. Remarkably, however, loss of hepatic WASHC1 may sensitize LRP1 for proprotein convertase subtilisin/kexin type 9–induced degradation. Altogether, these findings identify the WASH complex as a regulator of LDL as well as HDL metabolism and provide in vivo evidence for endosomal trafficking of scavenger receptor class B type I in hepatocytes.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

Hepatic ablation of Washc1 in mice destabilizes the WASH complex, alters lysosomal architecture, and raises plasma LDL-C and HDL-C by reducing hepatocyte surface LDLR/LRP1 and SR-BI, respectively. WASH deficiency also accelerates IDOL-mediated LDLR degradation and may sensitize LRP1 to PCSK9-induced degradation.

Key findings

  • In chow-fed Washc1 ΔHep mice, total plasma cholesterol increased without changes in triglycerides; LDL and HDL fractions were cholesterol-enriched, ApoB and ApoE were increased, and HDL particles were larger. With adenoviral human CETP expression, Washc1 ΔHep mice still had higher total cholesterol, LDL-C, HDL-C, ApoB, ApoA-I, and ApoE than WT mice.
  • Hepatic WASH loss reduced hepatocyte surface levels of LDLR and LRP1. PCSK9-D377Y expression exacerbated hypercholesterolemia in Washc1 ΔHep mice and increased ApoB48/ApoB100; LRP1 levels decreased upon PCSK9 overexpression only in WASH-deficient livers.
  • SR-BI surface levels were decreased in WASH-deficient primary hepatocytes, and selective hepatic HDL-CE uptake was reduced, while HDL holoparticle clearance was unchanged.
  • WASH deficiency accelerated IDOL-mediated LDLR degradation but did not affect PCSK9-mediated LDLR degradation in MEFs. Hepatic Washc1/Commd1 double knockout did not further increase total plasma cholesterol compared with single knockouts. Lysosomal tubulation was 14.8% (37/250) in Washc1-ablated hepatocytes versus 4.4% (11/250) in WT.

Methods

  • Liver-specific Washc1-knockout mice were generated by crossing Washc1 fl/fl mice with Alb-Cre mice; mice were 12–20 weeks old, predominantly male, chow-fed, and fasted 4 hours before sacrifice (n = 4–7). Additional models included liver-specific Commd1 knockout, AAV-PCSK9-D377Y, and Ad-CETP.
  • Analyses included primary hepatocyte biotinylation for surface LDLR, LRP1, and SR-BI; MEFs for PCSK9- and IDOL-mediated LDLR degradation; transmission EM; FPLC; targeted proteomics; radioactive HDL turnover; qRT-PCR; and hepatic lipid, biliary, and fecal sterol/bile acid measurements.
  • Statistics used unpaired two-tailed Student’s t test with P < 0.05; in vitro data were from 3 independent experiments.

Limitations

  • The paper does not include a dedicated limitations section. It states that the mechanism by which PCSK9 lowers hepatic LRP1 in Washc1 ΔHep mice is unclear and that future experiments are needed, and it suggests that more significant conditions may be required to unmask a biliary cholesterol phenotype.
  • Evident from the text: findings are from mouse models, predominantly male, chow-fed, with adenoviral/AAV perturbations; no human validation is presented, and the LRP1 sensitization conclusion is speculative.
  • Evident from the text: in vitro LDLR degradation experiments use MEFs rather than hepatocytes, and the Washc1/Commd1 double-knockout characterization focuses on plasma lipids rather than all proposed mechanisms.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1172/jci.insight.126462

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

24 of 34 cited sources checked · 7 supported · 0 flagged · accuracy not yet measured

  • Premisecitation

    Individuals heterozygous for a loss-of-function variant in SCARB1 (P376L) have increased levels of plasma HDL-C.

    “Individuals who are heterozygous for a loss-of-function variant in SCARB1 (P376L), the gene encoding SR-BI, have increased levels of plasma HDL-C (56).”
    Quote in the paperNot a substantial claim1 of 1 sources checked
  • Premisecitation

    Loss of the CCC complex leads to increased expression of several WASH subunits, including WASHC1.

    “we have shown that loss of the CCC complex leads to increased expression of several WASH subunits, including WASHC1 (17).”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [17] source

      In “Stability of COMMD Proteins Associated With the CCC Complex Depends on Other COMMD Proteins” (page unavailable), the paper reports that loss of COMMD1 or COMMD6 reduced CCC core subunits and increased expression of the WASH component WASH1, also called WASHC1. It does not report increased expression of several WASH subunits; its mention of FAM21 concerns colocalization, not increased expression. (LLM, conf=0.87)

      Experimental — accuracy not yet measured
  • Interpretationown data

    The itinerary of PCSK9-LDLR to the lysosome is spatially separated from the LDLR recycling route.

    “These data indicate that the itinerary of PCSK9-LDLR to the lysosome is spatially separated from the LDLR recycling route (11,23,63).”
    Quote in the paperSubstantial claim3 of 3 sources checked
    • cites [11] source

      The section “Retrieval and degradative functions of the endosome are spatially segregated” says that degradative and retrieval complexes occupy distinct endosomal subdomains, though it describes cargo segregation as a possibility. “The CCC complex” identifies LDLR as recycling cargo. The paper does not establish that PCSK9-bound LDLR specifically follows a spatially separate itinerary to the lysosome. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
    • cites [23] source

      The Abstract distinguishes endosomal recycling from lysosomal degradation, and the Results mention machinery involved in LDLR recycling, but neither addresses the itinerary of PCSK9-bound LDLR or its spatial relationship to the LDLR recycling route. Searches for PCSK9 and spatial separation found no passage making that comparison; no page numbers are available in our copy. (LLM, conf=0.75)

      Experimental — accuracy not yet measured
    • cites [63] source

      The ‘Cargo fate decisions at the endosome’ section (p. 4) describes recycling cargo being retrieved into tubular carriers rather than entering the degradative pathway, and the reference annotation (p. 35) identifies LDLR as a recycling cargo. The copy does not establish that PCSK9-bound LDLR follows a spatially separate itinerary to the lysosome. (LLM, conf=0.82)

      Experimental — accuracy not yet measured
  • Premisecitation

    Both LDL-C and HDL-C are elevated in patients with X-linked intellectual disability caused by mutations in CCDC22.

    “both LDL-C and HDL-C are elevated in patients with X-linked intellectual disability caused by mutations in the gene encoding the CCC-complex component CCDC22 (16).”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [16] Bartuzi, 2016, CCC- and WASH-mediated endosomal sorting of LDLR is required for normal clearance of circulating LDL, Nat Commun source

      The Results section, “CCDC22 mutations are associated with hypercholesterolaemia” (page unavailable), reports elevated LDL cholesterol in patients with CCDC22-related X-linked intellectual disability. It reports elevated total cholesterol, but does not establish that HDL cholesterol is elevated in those patients. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
  • Premisecitation

    A patient with RSS with a homozygous hypomorphic WASHC5 allele has relatively high plasma HDL-C levels.

    “plasma HDL-C levels were also reported to be relatively high in a patient with RSS with a homozygous hypomorphic WASHC5 allele (16).”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [16] Bartuzi, 2016, CCC- and WASH-mediated endosomal sorting of LDLR is required for normal clearance of circulating LDL, Nat Commun source

      The Results section (‘COMMD1 and WASH facilitate LDLR trafficking’; page unavailable) reports one RSS patient with a homozygous KIAA0196 mutation that reduced strumpellin levels, and gives the patient’s HDL-C as 1.5 mmol/L. It describes total and LDL cholesterol—not HDL-C—as elevated, so the characterization of HDL-C as ‘relatively high’ is not established by the paper. (LLM, conf=0.82)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim. 13
  • It may state two separate claims as one. 15
  • The quote only partly states this claim. 1
  • Probably not a substantial claim. The paper’s conclusions may not depend on it.

    Premisecitation

    Common genetic variants near SCARB1 are correlated with plasma HDL-C levels.

    “common genetic variants near SCARB1 have been found to be correlated with plasma HDL-C levels (57, 58)”
    Quote in the paperNot a substantial claim1 of 2 sources checked
    • cites [57] source

      The Abstract (page not provided) reports associations between serum lipid traits and SNPs near SCARB1, and New Biological, Clinical, and Genetic Insights (page not provided) identifies SCARB1 as a receptor for HDL-C. The passages do not specifically state that the variants near SCARB1 were associated with HDL-C levels, rather than another lipid trait. (LLM, conf=0.82)

      Experimental — accuracy not yet measured
    • cites [58] source
  • Probably not a substantial claim. The paper’s conclusions may not depend on it.

    Premisecitation

    Hepatic lipase increases hepatic HDL-CE uptake.

    “It has been shown that the enzyme hepatic lipase (HL) increases hepatic HDL-CE uptake (40-43).”
    Quote in the paperNot a substantial claim2 of 4 sources checked
    • cites [40] Amar, 1998, Hepatic lipase facilitates the selective uptake of cholesteryl esters from remnant lipoproteins in apoE-deficient mice, J Lipid Res source

      The passage indexed as Abstract (page unavailable) suggests that lipolysis may be required for HL-mediated enhanced selective uptake of HDL cholesteryl esters in apoE-deficient mice. It does not establish increased hepatic HDL-CE uptake: the measured increase in liver uptake was from VLDL cholesteryl ester, not HDL. (LLM, conf=0.85)

      Experimental — accuracy not yet measured
    • cites [41] source
    • cites [42] source
    • cites [43] source

      The Discussion says hepatic lipase enhances selective uptake of HDL-derived cholesteryl esters, citing previous studies. It does not specify that this uptake occurs in the liver; its discussion of a possible mechanism also considers delivery to adrenal cells. The hepatic location in the citing claim is therefore not established by our copy. (LLM, conf=0.83)

      Experimental — accuracy not yet measured
  • It may state two separate claims as one.

    Premisecitation

    A role for PCSK9 in hepatic LRP1 degradation in WT mice or in hepatic COMMD1-deficient mice could not be confirmed.

    “However, we and others could not confirm a role for PCSK9 in hepatic LRP1 degradation in WT mice, nor in hepatic COMMD1-deficient mice (17,37,38).”
    Quote in the paperNot a substantial claim2 of 3 sources checked
    • cites [17] source
    • cites [37] source

      Checked before — its earlier verdict is held back until a new check runs.

    • cites [38] source

      The Discussion reports that hepatic LRP protein levels were not significantly different in wild-type mice exposed to circulating PCSK9, supporting the WT-mouse part of the claim. The paper does not address hepatic COMMD1-deficient mice, so it cannot support that part. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.

    Premisecitation

    PCSK9 can bind to and decrease LRP1 in different cell lines.

    “It has been shown that PCSK9 can bind to and decrease LRP1 in different cell lines (64).”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [64] source

      The Results section, “PCSK9 enhances the degradation of LRP-1 in HEK293 and HepG2 cells” (page unavailable), reports decreased LRP-1 levels in multiple cell lines. The Discussion considers PCSK9–LRP-1 binding affinity, but the passages found do not establish direct binding, so that part of the claim is not fully supported. (LLM, conf=0.83)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim. It may state two separate claims as one.

    Premisecitation

    SR-BI is endocytosed and localized in recycling endosomes.

    “Several studies have shown that SR-BI is endocytosed (59,60) and localized in recycling endosomes (60).”
    Quote in the paperSubstantial claim2 of 2 sources checked
    • cites [59] source

      The section on holo-HDL particle uptake reports internalization of SR-BI-GFP alongside HDL, supporting SR-BI endocytosis. The passage on the endosomal recycling compartment describes HDL particles being transported there, not localization of SR-BI itself; the copy does not establish that part of the claim. Page numbers are unavailable in our copy. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
    • cites [60] source
  • It may state two separate claims as one.

    Interpretationcitation

    Hepatocyte-specific WASH deficiency leads to reduced LDLR and LRP1 levels in the plasma membrane, which likely underlies elevated plasma LDL-C levels in Washc1 ΔHep mice.

    “In agreement with our in vitro studies (16), hepatocyte-specific WASH deficiency leads to reduced LDLR and LRP1 levels in the plasma membrane, which likely underlies elevated plasma LDL-C levels in Washc1 ΔHep mice.”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [16] Bartuzi, 2016, CCC- and WASH-mediated endosomal sorting of LDLR is required for normal clearance of circulating LDL, Nat Commun source

      The Results section, “COMMD1 and WASH facilitate LDLR trafficking” (page unavailable), reports reduced cell-surface LDLR and LDL uptake in WASH1-deficient mouse embryonic fibroblasts, supporting the reference to in vitro studies. It does not establish reduced plasma-membrane LRP1 or elevated LDL-C in hepatocyte-specific WASH-deficient mice; its hepatic knockout results concern Commd1 instead. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
  • The quote only partly states this claim.

    Findingown data

    Hepatic ablation of Washc1 in chow-fed mice increases plasma HDL cholesterol.

    “We also found the HDL fraction to be enriched with cholesterol and increased in size (Figure 2C).”
    Quote in the paperSubstantial claim
  • It may state two separate claims as one.

    Findingreasoning

    Impairment of the WASH-CCC axis only leads to reduced HDL-CE uptake without affecting ApoA-I clearance or its plasma levels.

    “an impairment of the WASH-CCC axis only led to reduced HDL-CE uptake without affecting ApoA-I clearance as well as its plasma levels”
    Quote in the paperSubstantial claim
  • It may state two separate claims as one.

    Findingown data

    Hepatic ablation of both WASH and CCC complexes results in increased plasma LDL-C and larger HDL-C particles similar to single knockouts.

    “In addition, hepatic ablation of both complexes also resulted in increased plasma LDL-C (Figure 6, C and D) and larger HDL-C particles (Figure 6, C and D), similar to that was seen in single-knockout models”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim. The paper’s conclusions may not depend on it.

    Findingown data

    Hepatic LXR activity is slightly reduced upon Washc1 ablation.

    “Although hepatic LXR activity was slightly reduced upon Washc1 ablation”
    Quote in the paperNot a substantial claim
  • It may state two separate claims as one.

    Findingown data

    Renal uptake rate of HDL-CE is much lower than hepatic HDL-CE uptake, and no differences are observed between WT and Washc1 ΔHep mice.

    “the renal uptake rate of HDL-CE was much lower than with hepatic HDL-CE uptake, and no differences were observed between WT and Washc1 ΔHep mice (data not shown).”
    Quote in the paperNot a substantial claim
  • It may state two separate claims as one.

    Findingown data

    Targeted proteomics shows a leftward shift of ApoA-I and ApoE in Washc1/Commd1 ΔHep mice, confirming that HDL particles are larger.

    “targeted proteomics analysis of FPLC fractions showed a leftward shift of ApoA-I and ApoE (Figure 6E), confirming that the HDL particles are also larger in Washc1/Commd1 ΔHep mice”
    Quote in the paperNot a substantial claim
  • It may state two separate claims as one.

    Findingown data

    Female Washc1 ΔHep mice also show increased total cholesterol, LDL-C, and larger HDL particles.

    “An increase in TC, LDL-C, and larger HDL particles was also seen in female Washc1 ΔHep mice (Supplemental Figure 2, A-C).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim.

    Interpretationown data

    This work provides insights into the role of the WASH complex in IDOL- and PCSK9-mediated LDLR degradation.

    “our work provides insights in the role of the WASH complex in IDOL-and PCSK9-mediated LDLR degradation.”
    Quote in the paperSubstantial claim
  • It may state two separate claims as one.

    Interpretationown data

    Hepatic WASHC1 deficiency does not result in dysfunctional lysosomes and aberrant intracellular cholesterol transport or cholesterol synthesis, despite abnormal architecture.

    “Altogether, our data provide no evidence that hepatic WASHC1 deficiency results in dysfunctional lysosomes and aberrant intracellular cholesterol transport or cholesterol synthesis, despite their abnormal architecture.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim.

    Premisecitation

    In mice, the role of hepatic LRP1 in the clearance of plasma cholesterol is redundant, as LDLR can compensate for LRP1 loss.

    “In mice, the role of hepatic LRP1 in the clearance of plasma cholesterol is redundant, as LDLR can compensate for LRP1 loss (35).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [35] source
  • It may state two separate claims as one.

    Interpretationown data

    The WASH complex participates in the IDOL-LDLR degradation pathway but not in the PCSK9-LDLR axis.

    “Taken together, these results suggest that the WASH complex participates in the IDOL-LDLR degradation pathway but not in the PCSK9-LDLR axis.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim.

    Premisecitation

    In mice, HDL-C is mainly cleared by SR-BI, which selectively takes up CE from HDL rather than internalizing the holoparticle.

    “In mice, HDL-C is mainly cleared by SR-BI, a membrane receptor that selectively takes up CE from HDL rather than internalizing the holoparticle (39).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [39] source
  • It may state two separate claims as one.

    Interpretationreasoning

    Both the CCC and WASH complexes are required for efficient hepatic LDL-C and HDL-C uptake in men and mice.

    “suggesting that both the CCC and WASH complexes are required for efficient hepatic LDL-C and HDL-C uptake in men and mice.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The function of the WASH complex in hepatic lipoprotein receptor trafficking is conserved between mice and humans.
  • Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.

    Interpretationown data

    No changes in biliary cholesterol excretion were found, which may suggest that a compensatory adaptive response is induced.

    “Yet, we did not find any changes in biliary cholesterol excretion, which may suggest that a compensatory adaptive response is induced.”
    Quote in the paperNot a substantial claim
  • It may state two separate claims as one.

    Interpretationown data

    Hepatic depletion of WASH impairs the functioning of both LDLR and LRP1 in the uptake of plasma cholesterol, leading to hypercholesterolemia.

    “These data demonstrate that hepatic depletion of WASH impairs the functioning of both LDLR and LRP1 in the uptake of plasma cholesterol leading to hypercholesterolemia”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim.

    Premisecitation

    The endolysosomal system is fundamental for the PCSK9- and IDOL-mediated degradation pathways.

    “The endolysosomal system is fundamental for the PCSK9-and IDOL-mediated degradation pathways (18)(19)(20)(21)(22).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites (18)(19)(20)(21)(22)

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • It may state two separate claims as one.

    Premisecitation

    The interaction between the CCC and WASH complexes is required for localization of the CCC complex to endosomes and for endosomal trafficking of integral membrane proteins.

    “This interaction is required for the localization of the CCC complex to endosomes and subsequently for endosomal trafficking of integral membrane proteins.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim. The paper’s conclusions may not depend on it.

    Study design and conductnone given

    For EM analysis, 25 random images per block were collected for each mouse per condition, giving 100 random images per condition.

    “Twenty-five random images per block were collected for each mouse per condition (100 random images per condition).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim. The paper’s conclusions may not depend on it.

    Study design and conductown data

    In vitro data were obtained from 3 independent experiments.

    “In vitro data were obtained from 3 independent experiments ± SEM.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim. The paper’s conclusions may not depend on it.

    Study design and conductnone given

    All animal studies were approved by the Institutional Animal Care and Use Committee, University of Groningen (Groningen, the Netherlands).

    “All animal studies were approved by the Institutional Animal Care and Use Committee, University of Groningen (Groningen, the Netherlands).”
    Quote in the paperNot a substantial claim
26 of 26
  • The paper relies on this without support.

    The function of the WASH complex in hepatic lipoprotein receptor trafficking is conserved between mice and humans.

    “suggesting that both the CCC and WASH complexes are required for efficient hepatic LDL-C and HDL-C uptake in men and mice.”
    “this study extends the mechanistic basis for the increased plasma cholesterol levels in humans with defects in the WASH-CCC axis”
1 of 1

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • Stated mouse sample-size range excludes a reported group

    Minor

    The Methods give a mouse sample-size range of 4-7, while the Figure 6 legend reports groups of up to 9 mice.

  • Methods say all experiments used male mice despite reported female-mouse results

    Minor

    The Methods state that all experiments used male mice, but the Results explicitly report an experiment in female mice.

  • PCSK9 dose differs by 1,000-fold

    Minor

    The Figure 7 legend gives a PCSK9 concentration of 2.5 mg/ml, whereas the Results and Methods give 2.5 μg/ml for the same MEF incubation.

  • CETP and non-CETP figure references are reversed

    Minor

    The comparison identifies Figure 2C as the CETP-expressing condition and Figure 3C as the condition without CETP, but the Figure 3 caption explicitly identifies Figure 3C as after Ad-CETP administration.

4 of 4

Citations

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Metadata

Authors
Wijers, M., Zanoni, P., Liv, N., Vos, D. Y., Jäckstein, M. Y., Smit, M., Wilbrink, S., Wolters, J. C., van der Veen, Y. T., Huijkman, N., Dekker, D., Kloosterhuis, N., van Dijk, T. H., Billadeau, D. D., Kuipers, F., Klumperman, J., von Eckardstein, A., Kuivenhoven, J. A., & van de Sluis, B.
Affiliations
  • University Medical Center Groningen (NL)
  • University of Zurich (CH)
  • Utrecht University (NL)
  • Mayo Clinic (US)
Corresponding author
van de Sluis, Bart
Venue
JCI Insight
Published
2019-06-06
Volume
4
Issue
11
ISSN
2379-3708 (ISSN-L)
OpenAlex
W2948659925
Cited by
44
References
74
Citations by year
2026: 5 · 2025: 6 · 2024: 5 · 2023: 7 · 2022: 10 · 2021: 7 · 2020: 3 · 2019: 1
FWCI
2.22
Type
journal article
Language
en
Open access
Locations
  • JCI Insight (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
  • Utrecht University Repository (Utrecht University) (submittedVersion)
  • Zurich Open Repository and Archive (University of Zurich)
Funders
  • NWO-ALW (817.02.022)
  • EU FP7 (TransCard (FP7-603091-2))
  • the Dutch heart foundation (CVON 2017-20)
  • dutch heart foundation (2015T068)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Keywords
WASH complex, LDL cholesterol, HDL cholesterol, LDL receptor, LRP1, scavenger receptor class B type I, endosomal trafficking, PCSK9, endosomal recycling, hepatocytes, serum cholesterol
MeSH terms
Animals, Female, Cholesterol, HDL, Cholesterol, LDL, Liver, Male, Mice, Inbred C57BL, Mice, Transgenic, Microfilament Proteins, Vesicular Transport Proteins, Scavenger Receptors, Class B, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review